SCHEMBL14067384

SCHEMBL14067384

Cc1cc(I)cn2cc(-c3ccc(N(C)C)nc3)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.43
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
ALDH1A1 P00352 4/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
GAA P10253 2/20 0.37
MAP3K11 Q16584 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
CRHR1 P34998 2/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 3/20 0.36
TP53 P04637 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
HSD17B10 Q99714 2/20 0.36
PKM P14618 1/20 0.36
POLB P06746 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
SYK P43405 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14067385 0.85 NPC1 (0.44) APPNPC1RAB9AALDH1A1NFKB1
SCHEMBL14067374 0.79 APP (0.40) APPNPC1RAB9AGAAMAP3K11
SCHEMBL14067366 0.78 APP (0.67) APPNPC1RAB9AALDH1A1KDM4E
SCHEMBL14067382 0.78 APP (0.43) APPNPC1RAB9AALDH1A1KDM4E
SCHEMBL14067394 0.76 APP (0.43) APPNPC1RAB9AALDH1A1NFKB1
SCHEMBL14067370 0.76 TLR9 (0.47) APPNPC1RAB9AALDH1A1GAA
SCHEMBL14067397 0.75 APP (0.40) APP
SCHEMBL14067381 0.75 APP (0.43) APPNPC1RAB9AALDH1A1KDM4E
SCHEMBL14067376 0.74 APP (0.39) APPNPC1RAB9AGAACRHR1
SCHEMBL14067400 0.73 APP (0.41) APPNPC1RAB9AGAAMAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080219922-A1 Alzheimer's Disease Imaging Agents EMORY UNIVERSITY 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080219922-A1 Alzheimer's Disease Imaging Agents APP, PSEN1, MAPT APP 1/4885NPC1 48/4885RAB9A 1812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.